Evvy is a New York-based precision medicine company for women's health built around what it describes as the world's largest proprietary, clinical-grade dataset on the vaginal microbiome and women's health outcomes. Its at-home test uses CLIA-certified, NYS CLEP-approved metagenomic sequencing to screen for more than 700 bacteria and fungi, with results ordered and interpreted by licensed clinicians and paired with personalized prescription treatment and longitudinal biomarker tracking. The platform serves over 100,000 patients and 3,000 practitioners in the United States, has generated 13 peer-reviewed publications, and powers EvvyAI, a machine-learning advisor the company is extending from vaginal health into fertility care.
1
Round
1
Industry
3
Tags
Sep 15, 2026
Latest raise
Funding activity · 1 round
Sep 15, 2026
$40M
Series B
Led by Catalio Capital Management
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
